Is metronidazole safe to use in the first trimester of pregnancy, and what is the appropriate dosing regimen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole in First Trimester of Pregnancy

Metronidazole is contraindicated during the first trimester of pregnancy and treatment must be deferred until after 12 weeks gestation. 1, 2

Timing of Treatment

  • First trimester (0-12 weeks): Metronidazole is absolutely contraindicated due to concerns about fetal organogenesis, as the drug crosses the placental barrier rapidly and its effects on early fetal development are not fully established. 2

  • After first trimester (≥13 weeks): Treatment is recommended with metronidazole 2 g orally as a single dose to minimize total fetal drug exposure while achieving effective cure rates of approximately 90-95%. 1, 2

  • If symptomatic during first trimester: Treatment must be delayed until the second trimester begins, even in the presence of symptoms. 2

Rationale for Post-First-Trimester Treatment

The decision to treat after the first trimester balances two competing concerns:

  • Maternal and fetal risks of untreated infection: Trichomoniasis and bacterial vaginosis are associated with serious adverse pregnancy outcomes including premature rupture of membranes, preterm delivery, low birth weight, postpartum endometritis, and post-cesarean wound infection. 2, 3

  • Fetal safety data: Multiple meta-analyses and prospective cohort studies demonstrate that metronidazole exposure in the second and third trimesters shows no statistically significant increase in preterm birth, low birth weight, or congenital anomalies. 3, 4

Evidence Regarding First-Trimester Safety

While older research suggests metronidazole may not be teratogenic even in the first trimester 5, 6, 4, current CDC guidelines maintain the first-trimester contraindication as the standard of care. 1, 2 This conservative approach reflects:

  • One study found a 70% increased risk of spontaneous abortion with metronidazole use, though this may be confounded by the severity of underlying genitourinary infection. 7

  • The FDA classifies metronidazole as Pregnancy Category B, indicating animal studies show no fetal risk but adequate human studies are lacking. 3

  • Guidelines prioritize avoiding any potential risk during the critical period of organogenesis (weeks 3-8 of gestation). 2

Recommended Dosing After First Trimester

For trichomoniasis:

  • Preferred regimen: Metronidazole 2 g orally as a single dose. 1, 2, 3
  • Alternative regimen: Metronidazole 500 mg orally twice daily for 7 days. 2, 3

For bacterial vaginosis:

  • Preferred regimen: Metronidazole 250 mg orally three times daily for 7 days. 3
  • Alternative options: Single 2 g oral dose or intravaginal metronidazole gel 0.75%. 3

Critical Management Points

Partner treatment is mandatory:

  • All sexual partners must receive simultaneous treatment with the same metronidazole regimen, regardless of symptoms, as untreated partners are the leading cause of treatment failure and reinfection. 2
  • Patients must abstain from sexual intercourse until both partners complete therapy and are asymptomatic. 1, 2

Alcohol avoidance:

  • Counsel patients to avoid all alcohol during treatment and for at least 24 hours after the last metronidazole dose to prevent severe disulfiram-like reactions (flushing, nausea, vomiting, tachycardia). 3

Common Pitfalls to Avoid

  • Do not treat during the first trimester even if the patient is symptomatic—defer until week 13. 2

  • Do not use metronidazole gel for trichomoniasis as it achieves cure rates below 50% and is ineffective. 2

  • Do not omit partner treatment as this is the primary driver of recurrent infection. 2

  • Do not use clindamycin vaginal cream in second/third trimesters as clinical trials reported higher rates of prematurity and neonatal infections. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment and Prevention of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Metronidazole Use in the Third Trimester of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Safety of metronidazole in pregnancy: a meta-analysis.

American journal of obstetrics and gynecology, 1995

Research

Metronidazole appears not to be a human teratogen: review of literature.

Infectious diseases in obstetrics and gynecology, 1997

Research

The safety of metronidazole in pregnancy.

Health care for women international, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.